BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9617748)

  • 1. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.
    Decker MW; Bannon AW; Buckley MJ; Kim DJ; Holladay MW; Ryther KB; Lin NH; Wasicak JT; Williams M; Arneric SP
    Eur J Pharmacol; 1998 Apr; 346(1):23-33. PubMed ID: 9617748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.
    Bannon AW; Decker MW; Curzon P; Buckley MJ; Kim DJ; Radek RJ; Lynch JK; Wasicak JT; Lin NH; Arnold WH; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):787-94. PubMed ID: 9580627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats.
    Boyce S; Webb JK; Shepheard SL; Russell MGN; Hill RG; Rupniak NMJ
    Pain; 2000 Apr; 85(3):443-450. PubMed ID: 10781917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain.
    Joshi SK; Mikusa JP; Weaver B; Honore P
    J Pain; 2008 Feb; 9(2):146-56. PubMed ID: 18088559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons.
    Bitner RS; Nikkel AL; Curzon P; Arneric SP; Bannon AW; Decker MW
    J Neurosci; 1998 Jul; 18(14):5426-32. PubMed ID: 9651224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594.
    Decker MW; Curzon P; Holladay MW; Nikkel AL; Bitner RS; Bannon AW; Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Williams M; Arneric SP
    J Physiol Paris; 1998; 92(3-4):221-4. PubMed ID: 9789812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
    Bannon AW; Decker MW; Holladay MW; Curzon P; Donnelly-Roberts D; Puttfarcken PS; Bitner RS; Diaz A; Dickenson AH; Porsolt RD; Williams M; Arneric SP
    Science; 1998 Jan; 279(5347):77-81. PubMed ID: 9417028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of tebanicline for various noxious stimuli-induced behaviours in mice.
    Hayashi T; Katsuyama S; Orito T; Suzuki T; Sakurada S
    Neurosci Lett; 2017 Jan; 638():46-50. PubMed ID: 27939354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594.
    Munro G; Dyhr H; Grunnet M
    Neuropharmacology; 2010 Sep; 59(3):208-17. PubMed ID: 20562022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
    Holladay MW; Wasicak JT; Lin NH; He Y; Ryther KB; Bannon AW; Buckley MJ; Kim DJ; Decker MW; Anderson DJ; Campbell JE; Kuntzweiler TA; Donnelly-Roberts DL; Piattoni-Kaplan M; Briggs CA; Williams M; Arneric SP
    J Med Chem; 1998 Feb; 41(4):407-12. PubMed ID: 9484491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model.
    Lynch JJ; Wade CL; Mikusa JP; Decker MW; Honore P
    Eur J Pharmacol; 2005 Feb; 509(1):43-8. PubMed ID: 15713428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
    Yousofizadeh S; Tamaddonfard E; Farshid AA
    Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
    Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
    J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice.
    Yue CQ; Ye J; Li CL; Li RT; Sun Q
    Pharmacol Biochem Behav; 2007 Apr; 86(4):643-50. PubMed ID: 17379285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
    Skoubis PD; Hradil V; Chin CL; Luo Y; Fox GB; McGaraughty S
    Neuroscience; 2006; 137(2):583-91. PubMed ID: 16289887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
    Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
    Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
    Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-induced anxiolytic-like effect in morphine-sensitized mice: involvement of ventral hippocampal nicotinic acetylcholine receptors.
    Rezayof A; Assadpour S; Alijanpour S
    Pharmacol Biochem Behav; 2013 Jan; 103(3):460-6. PubMed ID: 23067878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.